ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $201,252 | -3.2% | 8,403 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $208,000 | +20.2% | 8,596 | -17.6% | 0.00% | 0.0% |
| Q3 2021 | $173,000 | -32.9% | 10,438 | -1.4% | 0.00% | -33.3% |
| Q2 2021 | $258,000 | -14.3% | 10,590 | -9.2% | 0.00% | -25.0% |
| Q1 2021 | $301,000 | -64.1% | 11,661 | -25.3% | 0.00% | -60.0% |
| Q4 2020 | $838,000 | -99.8% | 15,603 | +21.4% | 0.01% | 0.0% |
| Q3 2020 | $530,000,000 | – | 12,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |